Grail Expands Blood Test to Symptomatic Patients, Aims to Revolutionize Cancer Diagnosis

Grail, a blood testing company, is expanding its commercial blood test, Galleri, to include symptomatic patients suspected of having cancer. The test aims to detect genetic fingerprints of cancer in the blood and offers a simpler and potentially less invasive diagnostic method.